{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:49:10Z","timestamp":1795045750567,"version":"4.10.2"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General and Comparative Endocrinology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ygcen.2024.114513","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T02:04:29Z","timestamp":1712714669000},"page":"114513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["The role of TGF-\u03b2 signaling in muscle atrophy, sarcopenia and cancer cachexia"],"prefix":"10.1016","volume":"353","author":[{"given":"Xin-Qiang","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Wei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8668-5931","authenticated-orcid":false,"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule","volume":"34","author":"Aartsma-Rus","year":"2006","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/jcsm.12442","article-title":"Association of lifestyle factors and inflammation with sarcopenic obesity: data from the PREDIMED-Plus trial","volume":"10","author":"Abete","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1\u20132","key":"10.1016\/j.ygcen.2024.114513_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000452522","article-title":"Angiotensin-(1\u20137) prevents skeletal muscle atrophy induced by transforming growth factor type beta (TGF-\u03b2) via mas receptor activation","volume":"40","author":"\u00c1brigo","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.ygcen.2024.114513_b0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/1389203718666171117101916","article-title":"Central role of transforming growth factor type beta 1 in skeletal muscle dysfunctions: an update on therapeutic strategies","volume":"19","author":"Abrigo","year":"2018","journal-title":"Curr. Protein Pept. Sci."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0030","first-page":"1","article-title":"Multiscale analysis of a regenerative therapy for treatment of volumetric muscle loss injury","volume":"4","author":"Aguilar","year":"2018","journal-title":"Cell Death Discovery"},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/age.12696","article-title":"The myostatin gene: an overview of mechanisms of action and its relevance to livestock animals","volume":"49","author":"Aiello","year":"2018","journal-title":"Anim. Genet."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0040","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jcsm.12647","article-title":"Blocking myostatin: muscle mass equals muscle strength?","volume":"11","author":"Anker","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/nutrit\/nuac062","article-title":"Age-related muscle anabolic resistance: inevitable or preventable?","volume":"81","author":"Aragon","year":"2023","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ygcen.2024.114513_b0055","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ejphar.2011.07.007","article-title":"Anti-inflammatory therapies in cancer cachexia","volume":"668","author":"Argil\u00e9s","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0060","doi-asserted-by":"crossref","DOI":"10.4081\/ejtm.2019.7960","article-title":"Therapeutic strategies against cancer cachexia","volume":"29","author":"Argil\u00e9s","year":"2019","journal-title":"Eur. J. Transl. Myol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Argil\u00e9s","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0070","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7150\/ijms.22723","article-title":"Resveratrol attenuates denervation-induced muscle atrophy due to the blockade of atrogin-1 and p62 accumulation","volume":"15","author":"Asami","year":"2018","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1535370217749494","article-title":"Myogenic regulatory factors: the orchestrators of myogenesis after 30 years of discovery","volume":"243","author":"Asfour","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0080","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1245\/s10434-011-1720-5","article-title":"Changes in myostatin signaling in non-weight-losing cancer patients","volume":"19","author":"Aversa","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"19","key":"10.1016\/j.ygcen.2024.114513_b0085","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1113\/jphysiol.2011.212845","article-title":"Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids","volume":"589","author":"Baehr","year":"2011","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.11005\/jbm.2020.27.2.97","article-title":"Rodent model of muscular atrophy for sarcopenia study","volume":"27","author":"Baek","year":"2020","journal-title":"J. Bone Metab."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ygcen.2024.114513_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fnut.2019.00146","article-title":"The role of the IGF-1 signaling cascade in muscle protein synthesis and anabolic resistance in aging skeletal muscle","volume":"6","author":"Barclay","year":"2019","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ygcen.2024.114513_b0105","article-title":"Myostatin and muscle atrophy during chronic kidney disease","author":"Bataille","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ygcen.2024.114513_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13243","article-title":"Sarcopenia and health-related quality of life: a systematic review and meta-analysis","author":"Beaudart","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-017-0266-9","article-title":"A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1","volume":"22","author":"Bian","year":"2017","journal-title":"Eur. J. Med. Res."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0120","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0125","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/138920207783591672","article-title":"Myostatin in the pathophysiology of skeletal muscle","volume":"8","author":"Bonnieu","year":"2007","journal-title":"Curr. Genomics"},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/SHK.0000000000001183","article-title":"Association between muscle wasting and muscle strength in patients who developed severe sepsis and septic shock","volume":"51","author":"Borges","year":"2019","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0145","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer cachexia: beyond weight loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"J. Oncol. Pract."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2044-5040-1-19","article-title":"Role of TGF-\u03b2 signaling in inherited and acquired myopathies","volume":"1","author":"Burks","year":"2011","journal-title":"Skelet. Muscle"},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152210793663810","article-title":"Metabolic functions of myostatin and GDF11","volume":"10","author":"C McPherron","year":"2010","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.ygcen.2024.114513_b0165","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1073\/pnas.1525795113","article-title":"Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice","volume":"113","author":"Camporez","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ygcen.2024.114513_b0170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/978-981-13-1435-3_29","article-title":"Muscle atrophy: present and future","author":"Cao","year":"2018","journal-title":"Muscle Atrophy"},{"issue":"8","key":"10.1016\/j.ygcen.2024.114513_b0175","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s12603-018-1068-7","article-title":"Frailty, comorbidity, and COPD","volume":"22","author":"Charbek","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.ygcen.2024.114513_b0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-27511-6_5","article-title":"The TGF-\u03b2 signalling network in muscle development, adaptation and disease","volume":"900","author":"Chen","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ygcen.2024.114513_b0185","series-title":"Growth Factors and Cytokines in Skeletal Muscle Development, Growth, Regeneration and Disease","first-page":"97","article-title":"The TGF-\u03b2 signalling network in muscle development, adaptation and disease","author":"Chen","year":"2016"},{"key":"10.1016\/j.ygcen.2024.114513_b0190","doi-asserted-by":"crossref","unstructured":"Chen, X., Han, P., Yu, X., Zhang, Y., Song, P., Liu, Y., et al., 2020. Sarcopenia and Coronary Heart Disease Synergistically Increase the Risk of New Onset Depressive Symptoms in Older Adults.","DOI":"10.21203\/rs.3.rs-112175\/v1"},{"issue":"26","key":"10.1016\/j.ygcen.2024.114513_b0195","doi-asserted-by":"crossref","first-page":"E5266","DOI":"10.1073\/pnas.1620013114","article-title":"Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ygcen.2024.114513_b0200","first-page":"1","article-title":"Transforming growth factor-\u03b2 receptors: versatile mechanisms of ligand activation","author":"Chia","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.beha.2017.09.001","article-title":"Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting","volume":"30","author":"Ciechanover","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-\u03b2\u2013induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ygcen.2024.114513_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12752","article-title":"The impact of sarcopenia and acute muscle mass loss on long-term outcomes in critically ill patients with intra-abdominal sepsis","author":"Cox","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0225","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/cbin.10725","article-title":"The role of TGF-\u03b21 during skeletal muscle regeneration","volume":"41","author":"Delaney","year":"2017","journal-title":"Cell Biol. Int."},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0230","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s43587-021-00136-1","article-title":"Toward the recognition and management of sarcopenia in routine clinical care","volume":"1","author":"Dent","year":"2021","journal-title":"Nature Aging"},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0235","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ijo.2015.200","article-title":"Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues","volume":"40","author":"Dong","year":"2016","journal-title":"Int. J. Obes. (Lond)"},{"issue":"13","key":"10.1016\/j.ygcen.2024.114513_b0240","first-page":"1","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Dongsheng Duan","year":"2020","journal-title":"Nat. Rev."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0245","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cphy.c140068","article-title":"Satellite cells and skeletal muscle regeneration","volume":"5","author":"Dumont","year":"2015","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0250","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13420","article-title":"Identification of frailty and sarcopenia in hospitalised older people","volume":"51","author":"Echeverria","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cmet.2015.05.010","article-title":"GDF11 increases with age and inhibits skeletal muscle regeneration","volume":"22","author":"Egerman","year":"2015","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: an overview","volume":"2","author":"Elkina","year":"2011","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0265","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1748-1716.2012.02423.x","article-title":"The central role of myostatin in skeletal muscle and whole body homeostasis","volume":"205","author":"Elliott","year":"2012","journal-title":"Acta Physiol."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0270","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(00)81696-7","article-title":"Smads: Trancriptional activators of TGF-\u03b2 response","volume":"95","author":"Erynck","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ygcen.2024.114513_b0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/bs.acc.2021.09.006","article-title":"Myostatin: basic biology to clinical application","volume":"106","author":"Esposito","year":"2022","journal-title":"Adv. Clin. Chem."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0280","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s00198-011-1611-4","article-title":"Bone fracture and bone fracture repair","volume":"22","author":"Fazzalari","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0285","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy","volume":"461","author":"Foletta","year":"2011","journal-title":"Pflugers Arch.-Eur. J. Physiol."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ggi.13591","article-title":"Sarcopenia and dysphagia: position paper by four professional organizations","volume":"19","author":"Fujishima","year":"2019","journal-title":"Geriatr. Gerontol. Int."},{"issue":"25","key":"10.1016\/j.ygcen.2024.114513_b0295","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ygcen.2024.114513_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101531","article-title":"Redox modulation of muscle mass and function","volume":"35","author":"Gomez-Cabrera","year":"2020","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0305","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-\u03b2 superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17512433.2019.1555468","article-title":"Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies","volume":"12","author":"Hamed","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0657-0","article-title":"Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning","volume":"17","author":"Han","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"10","key":"10.1016\/j.ygcen.2024.114513_b0320","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ygcen.2024.114513_b0325","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","article-title":"The role of the TGF-\u03b2 superfamily in myocardial infarction","volume":"6","author":"Hanna","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0330","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2015.014","article-title":"Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophy","volume":"26","author":"Harish","year":"2015","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0335","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jcsm.12438","article-title":"Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)","volume":"10","author":"Harish","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ygcen.2024.114513_b0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fphys.2020.00184","article-title":"Inhibition of myostatin reduces collagen deposition in a mouse model of oculopharyngeal muscular dystrophy (OPMD) with established disease","volume":"11","author":"Harish","year":"2020","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.ygcen.2024.114513_b0345","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022079","article-title":"Transcriptional control by the SMADs","volume":"8","author":"Hill","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"12","key":"10.1016\/j.ygcen.2024.114513_b0350","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022103","article-title":"Structural biology and evolution of the TGF-\u03b2 family","volume":"8","author":"Hinck","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010095","article-title":"Integrated amino acids and transcriptome analysis reveals arginine transporter SLC7A2 is a novel regulator of myogenic differentiation","volume":"25","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygcen.2024.114513_b0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/biotarget.2018.05.02","article-title":"Strategies and potential therapeutic agents to counter skeletal muscle atrophy","volume":"2","author":"Huang","year":"2018","journal-title":"Biotarget"},{"issue":"10","key":"10.1016\/j.ygcen.2024.114513_b0365","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/ijms20102446","article-title":"Role of transforming growth factor-\u03b2 in skeletal muscle fibrosis: a review","volume":"20","author":"Ismaeel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.ygcen.2024.114513_b0370","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1096\/fj.02-0312com","article-title":"Patterns of gene expression in atrophying skeletal muscles: response to food deprivation","volume":"16","author":"Jagoe","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2011.03.004","article-title":"The epidemiology of sarcopenia","volume":"27","author":"Janssen","year":"2011","journal-title":"Clin. Geriatr. Med."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0380","first-page":"408","article-title":"Linking age-related changes in skeletal muscle mass and composition with metabolism and disease","volume":"9","author":"Janssen","year":"2005","journal-title":"J. Nutr. Health Aging"},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0385","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"issue":"04","key":"10.1016\/j.ygcen.2024.114513_b0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4236\/ojmip.2012.24018","article-title":"Growth and differentiation factor-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation","volume":"02","author":"Jeanplong","year":"2012","journal-title":"Open J. Mol. Integr. Physiol."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0395","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0838.2005.00498.x","article-title":"The possible role of myostatin in skeletal muscle atrophy and cachexia","volume":"16","author":"Jespersen","year":"2006","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.ygcen.2024.114513_b0400","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.19139.1","article-title":"Mitochondrial dysregulation and muscle disuse atrophy","volume":"8","author":"Ji","year":"2019","journal-title":"F1000Research"},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0405","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thoraxjnl-2014-206440","article-title":"Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation","volume":"70","author":"Jones","year":"2015","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10354-018-0618-2","article-title":"Sarcopenia","volume":"169","author":"Keller","year":"2019","journal-title":"Wien. Med. Wochenschr."},{"issue":"8","key":"10.1016\/j.ygcen.2024.114513_b0415","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/dmr.5610040805","article-title":"Endocrine regulation of protein breakdown in skeletal muscle","volume":"4","author":"Kettelhut","year":"1988","journal-title":"Diabetes Metab. Rev."},{"issue":"9","key":"10.1016\/j.ygcen.2024.114513_b0420","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/gerona\/glp068","article-title":"Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice","volume":"64A","author":"LeBrasseur","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ygcen.2024.114513_b0425","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.cellbio.20.012103.135836","article-title":"Regulation of muscle mass by myostatin","volume":"20","author":"Lee","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"49","key":"10.1016\/j.ygcen.2024.114513_b0430","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1073\/pnas.2019263117","article-title":"Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10585-006-9010-5","article-title":"Activin A circulating levels in patients with bone metastasis from breast or prostate cancer","volume":"23","author":"Leto","year":"2006","journal-title":"Clin. Exp. Metastasis"},{"issue":"22","key":"10.1016\/j.ygcen.2024.114513_b0440","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1101\/gad.925901","article-title":"TGF-\u03b2 inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3","volume":"15","author":"Liu","year":"2001","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0445","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.emboj.7600179","article-title":"TGF-\u03b2-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation","volume":"23","author":"Liu","year":"2004","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0450","doi-asserted-by":"crossref","DOI":"10.1186\/s13395-019-0193-2","article-title":"IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Skelet. Muscle"},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0455","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BJ20112024","article-title":"Myostatin is a novel tumoral factor that induces cancer cachexia","volume":"446","author":"Lokireddy","year":"2012","journal-title":"Biochem. J"},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0460","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","article-title":"Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy","volume":"28","author":"Long","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0465","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"Loumaye","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113288","article-title":"Naringenin improves muscle endurance via activation of the Sp1-ERRgamma transcriptional axis","volume":"42","author":"Lv","year":"2023","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0475","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","article-title":"STAT 3 promotes IFN \u03b3\/TNF \u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ygcen.2024.114513_b0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8260742","article-title":"Myokines as possible therapeutic targets in cancer cachexia","volume":"2018","author":"Manole","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0485","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","article-title":"Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches","volume":"8","author":"Mariot","year":"2017","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.ygcen.2024.114513_b0490","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1016\/S0021-9258(19)49859-1","article-title":"Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products","volume":"267","author":"Martin","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ygcen.2024.114513_b0495","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.ygcen.2024.114513_b0500","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massagu\u00e9","year":"2005","journal-title":"Genes Dev."},{"issue":"19","key":"10.1016\/j.ygcen.2024.114513_b0505","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0510","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/ijc.29620","article-title":"Tumor inoculation site affects the development of cancer cachexia and muscle wasting","volume":"137","author":"Matsuyama","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0515","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0277-5379(91)90483-T","article-title":"Anti-interferon-\u03b3 antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia","volume":"27","author":"Matthys","year":"1991","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0520","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135703","article-title":"TGF-\u03b2\u2013driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model","volume":"5","author":"M\u00e1zala","year":"2020","journal-title":"JCI insight"},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0525","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jcp.20757","article-title":"Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-\u03baB-independent, FoxO1-dependent mechanism","volume":"209","author":"McFarlane","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"6628","key":"10.1016\/j.ygcen.2024.114513_b0530","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ygcen.2024.114513_b0535","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.exger.2018.04.025","article-title":"Effects of aging and insulin resistant states on protein anabolic responses in older adults","volume":"108","author":"Morais","year":"2018","journal-title":"Exp. Gerontol."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0540","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 family: context-dependent roles in cell and tissue physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0545","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1371\/journal.pgen.0030079","article-title":"A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs","volume":"3","author":"Mosher","year":"2007","journal-title":"PLoS Genet."},{"issue":"9","key":"10.1016\/j.ygcen.2024.114513_b0550","first-page":"1948","article-title":"Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia","volume":"7","author":"Mota","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00441-011-1201-y","article-title":"Non-Smad signaling pathways","volume":"347","author":"Mu","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0560","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/35004013","article-title":"Ras is involved in nerve-activity-dependent regulation of muscle genes","volume":"2","author":"Murgia","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0565","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1096\/fj.10-159608","article-title":"Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function","volume":"24","author":"Murphy","year":"2010","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.ygcen.2024.114513_b0570","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.tem.2013.09.004","article-title":"Skeletal muscle autophagy: a new metabolic regulator","volume":"24","author":"Neel","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0575","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/abbs\/gmx126","article-title":"TGF-\u03b2 family co-receptor function and signaling","volume":"50","author":"Nickel","year":"2018","journal-title":"Acta Biochim. Biophy. Sin."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0580","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/db18-0416","article-title":"FoxO transcription factors are critical regulators of diabetes-related muscle atrophy","volume":"68","author":"O\u2019Neill","year":"2019","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0585","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.00277.2013","article-title":"Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models","volume":"306","author":"Ostler","year":"2014","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"key":"10.1016\/j.ygcen.2024.114513_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110801","article-title":"Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis","volume":"131","author":"Pacifico","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"22","key":"10.1016\/j.ygcen.2024.114513_b0595","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.3390\/ijms21228844","article-title":"Sarcopenia: molecular pathways and potential targets for intervention","volume":"21","author":"Pascual-Fern\u00e1ndez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0600","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1096\/fj.201600675r","article-title":"New function of the myostatin\/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration","volume":"31","author":"Pasteuning-Vuhman","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.ygcen.2024.114513_b0605","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0610","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ygcen.2024.114513_b0615","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7153610","article-title":"Modulating metabolism to improve cancer-induced muscle wasting","volume":"2018","author":"Penna","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ygcen.2024.114513_b0620","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fphys.2019.00041","article-title":"The skeletal muscle as an active player against cancer cachexia","volume":"10","author":"Penna","year":"2019","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0630","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/dvdy.24036","article-title":"Mechanisms of muscle growth and atrophy in mammals and Drosophila","volume":"243","author":"Piccirillo","year":"2014","journal-title":"Dev. Dyn."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0635","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"14","key":"10.1016\/j.ygcen.2024.114513_b0640","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.3390\/jcm12144770","article-title":"Fibrotic diseases of the human urinary and genital tract: current understanding and potential strategies for treatment","volume":"12","author":"Rahardjo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ygcen.2024.114513_b0645","series-title":"Absorption and Utilization of Amino Acids","first-page":"93","article-title":"Absorption and metabolism of amino acids studied in vitro, in vivo, and with computer simulations","author":"Reichl","year":"2019"},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0650","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3945\/an.113.005256","article-title":"Sarcopenia and the analysis of body composition","volume":"5","author":"Ribeiro","year":"2014","journal-title":"Adv. Nutr."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0655","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jocd.2015.04.014","article-title":"Nutrition and sarcopenia","volume":"18","author":"Rizzoli","year":"2015","journal-title":"J. Clin. Densitom."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0660","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0092-8674(94)90462-6","article-title":"Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules","volume":"78","author":"Rock","year":"1994","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.ygcen.2024.114513_b0665","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0670","doi-asserted-by":"crossref","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J. Nutr."},{"issue":"299","key":"10.1016\/j.ygcen.2024.114513_b0675","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0680","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/cncr.23802","article-title":"Lipolysis\u2014not inflammation, cell death, or lipogenesis\u2014is involved in adipose tissue loss in cancer cachexia","volume":"113","author":"Ryd\u00e9n","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygcen.2024.114513_b0685","series-title":"Sarcopenia","first-page":"145","article-title":"Sarcopenic obesity","author":"Sabico","year":"2021"},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0690","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"27","key":"10.1016\/j.ygcen.2024.114513_b0695","doi-asserted-by":"crossref","first-page":"21037","DOI":"10.1074\/jbc.M110.114959","article-title":"Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb","volume":"285","author":"Sako","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5\u20136","key":"10.1016\/j.ygcen.2024.114513_b0700","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00424-016-1933-3","article-title":"Molecular mechanism of sarcopenia and cachexia: recent research advances","volume":"469","author":"Sakuma","year":"2017","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0705","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0710","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP signaling controls muscle mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0725","first-page":"1107","article-title":"Understanding tumor anabolism and patient catabolism in cancer-associated cachexia","volume":"7","author":"Schcolnik-Cabrera","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"26","key":"10.1016\/j.ygcen.2024.114513_b0730","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2\u20133","key":"10.1016\/j.ygcen.2024.114513_b0735","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1024\/0300-9831\/a000064","article-title":"Protein turnover, ureagenesis and gluconeogenesis","volume":"81","author":"Schutz","year":"2011","journal-title":"Int. J. Vitam. Nutr. Res."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0740","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1143-6","article-title":"Bone Morphogenetic Proteins and myostatin pathways: key mediator of human sarcopenia","volume":"15","author":"Scimeca","year":"2017","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0745","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/neu.2017.5172","article-title":"Skeletal muscle atrophy and degeneration in a mouse model of traumatic brain injury","volume":"35","author":"Shahidi","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0750","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jcsm.13187","article-title":"tRNA-derived small RNA, 5'tiRNA-Gly-CCC, promotes skeletal muscle regeneration through the inflammatory response","volume":"14","author":"Shen","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0755","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.celrep.2016.09.010","article-title":"MyoD regulates skeletal muscle oxidative metabolism cooperatively with alternative NF-\u03baB","volume":"17","author":"Shintaku","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0760","first-page":"1","article-title":"Serum Myostatin Level in COPD Patients with and without sarcopenia-Application for biomarker of sarcopenia diagnosis","volume":"65","author":"Shinya Yoshida","year":"2019","journal-title":"Osaka City Med. J."},{"issue":"6184","key":"10.1016\/j.ygcen.2024.114513_b0765","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.1251152","article-title":"Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle","volume":"344","author":"Sinha","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ygcen.2024.114513_b0770","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Suzie Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0775","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acs.jnatprod.1c00271","article-title":"Eriocitrin contained in lemon peel ameliorates disuse muscle atrophy by suppressing the expression of atrogin-1 and MuRF-1 in denervated mice","volume":"84","author":"Takase","year":"2021","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0780","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jcsm.12251","article-title":"Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na\u00efve pancreatic cancer patients","volume":"9","author":"Talbert","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ygcen.2024.114513_b0785","series-title":"Advances in Food and Nutrition Research","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.afnr.2019.08.002","article-title":"Protein and amino acids for skeletal muscle health in aging","author":"Thalacker-Mercer","year":"2020"},{"key":"10.1016\/j.ygcen.2024.114513_b0790","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","article-title":"NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy","author":"Thoma","year":"2018","journal-title":"Muscle Atrophy"},{"issue":"51","key":"10.1016\/j.ygcen.2024.114513_b0795","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0800","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcsm.12238","article-title":"Skeletal muscle performance and ageing","volume":"9","author":"Tieland","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0805","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0810","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/jbmr.3416","article-title":"Sarcopenia and its clinical correlates in the general population: the Rotterdam study","volume":"33","author":"Trajanoska","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0815","doi-asserted-by":"crossref","first-page":"e13626","DOI":"10.1111\/acel.13626","article-title":"Protein restriction and branched-chain amino acid restriction promote geroprotective shifts in metabolism","volume":"21","author":"Trautman","year":"2022","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2044-5040-2-3","article-title":"TAK-1\/p38\/nNF\u03baB signaling inhibits myoblast differentiation by increasing levels of Activin A","volume":"2","author":"Trendelenburg","year":"2012","journal-title":"Skelet. Muscle"},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0825","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1152\/ajpendo.00161.2019","article-title":"Mitochondria dysfunction in aging and metabolic diseases: loss of mitochondrial energetics is associated with poor recovery of muscle function but not mass following disuse atrophy","volume":"317","author":"Trevino","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ygcen.2024.114513_b0830","first-page":"3576","article-title":"Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1","volume":"9","author":"Vaidya","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ygcen.2024.114513_b0835","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-\u03b2 receptors: in and beyond TGF-\u03b2 signaling","volume":"52","author":"Vander Ark","year":"2018","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0840","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.bor.0000245731.25383.de","article-title":"Mechanisms of skeletal muscle atrophy","volume":"18","author":"Ventadour","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0845","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.clnu.2017.01.005","article-title":"Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults\u2013The PROVIDE study","volume":"37","author":"Verlaan","year":"2018","journal-title":"Clin. Nutr."},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0850","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.116.308391","article-title":"Biochemistry and biology of GDF11 and myostatin","volume":"118","author":"Walker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ygcen.2024.114513_b0855","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.ygcen.2024.114513_b0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2049-4","article-title":"SPARCL1 promotes C2C12 cell differentiation via BMP7-mediated BMP\/TGF-\u03b2 cell signaling pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0865","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.intimp.2014.02.002","article-title":"Resveratrol prevents TNF-\u03b1-induced muscle atrophy via regulation of Akt\/mTOR\/FoxO1 signaling in C2C12 myotubes","volume":"19","author":"Wang","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.ygcen.2024.114513_b0870","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc min\/+ mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0875","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000356740","article-title":"Myostatin and Sarcopenia: opportunities and challenges - a mini-review","volume":"60","author":"White","year":"2014","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-08-0549","article-title":"The biology of activin: recent advances in structure, regulation and function","volume":"202","author":"Xia","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ygcen.2024.114513_b0885","first-page":"1","article-title":"Muscle atrophy","volume":"1088","author":"Xiao","year":"2018","journal-title":"Book"},{"issue":"7","key":"10.1016\/j.ygcen.2024.114513_b0890","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41401-020-00515-1","article-title":"Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-\u03b21\/TAK1 signaling pathway","volume":"42","author":"Xu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.ygcen.2024.114513_b0895","doi-asserted-by":"crossref","first-page":"e0191318","DOI":"10.1371\/journal.pone.0191318","article-title":"Inhibition of interleukin-6 decreases atrogene expression and ameliorates tail suspension-induced skeletal muscle atrophy","volume":"13","author":"Yakabe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ygcen.2024.114513_b0900","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fphys.2020.00445","article-title":"Cancer cachexia induces preferential skeletal muscle myosin loss when combined with denervation","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.ygcen.2024.114513_b0905","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.3892\/mmr.2020.11608","article-title":"Molecular mechanisms of cancer cachexia-induced muscle atrophy","volume":"22","author":"Yang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0910","first-page":"1","article-title":"Serum myostatin-immunoreactive protein is increased in 60\u201392 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.ygcen.2024.114513_b0915","article-title":"Skeletal muscle atrophy: from mechanisms to treatments","volume":"105807","author":"Yin","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0920","doi-asserted-by":"crossref","first-page":"551","DOI":"10.12965\/jer.1836268.134","article-title":"Role of exercise in age-related sarcopenia.","volume":"14","author":"Yoo","year":"2018","journal-title":"J. Exer. Rehab."},{"key":"10.1016\/j.ygcen.2024.114513_b0925","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00788","article-title":"mTOR as a key regulator in maintaining skeletal muscle mass","volume":"8","author":"Yoon","year":"2017","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0930","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2015.3845","article-title":"Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study","volume":"33","author":"Yuan","year":"2015","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0935","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022145","article-title":"TGF-\u03b2 family signaling in the control of cell proliferation and survival","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.ygcen.2024.114513_b0940","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2015.01.120","article-title":"PPAR\u03b3 and MyoD are differentially regulated by myostatin in adipose-derived stem cells and muscle satellite cells","volume":"458","author":"Zhang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygcen.2024.114513_b0945","article-title":"Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation","author":"Zhang","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.ygcen.2024.114513_b0950","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tem.2016.03.002","article-title":"Cytokine signaling in skeletal muscle wasting","volume":"27","author":"Zhou","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ygcen.2024.114513_b0955","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12542","article-title":"Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy","volume":"11","author":"Zhou","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ygcen.2024.114513_b0960","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["General and Comparative Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001664802400073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001664802400073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:16:21Z","timestamp":1716459381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001664802400073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":191,"alternative-id":["S001664802400073X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygcen.2024.114513","relation":{},"ISSN":["0016-6480"],"issn-type":[{"value":"0016-6480","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of TGF-\u03b2 signaling in muscle atrophy, sarcopenia and cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"General and Comparative Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygcen.2024.114513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114513"}}